# Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

> **NCT01124175** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Losartan
- **DRUG:** Cozaar®

## Key facts

- **NCT ID:** NCT01124175
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124175, "Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01124175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*